The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2026

Filed:

Feb. 25, 2025
Applicant:

Amunix Pharmaceuticals, Inc., South San Francisco, CA (US);

Inventors:

Viktoriya Dubrovskaya, San Francisco, CA (US);

Eric Johansen, Oakland, CA (US);

Sina Khorsand, El Cerrito, CA (US);

Lucas Liu, San Bruno, CA (US);

Volker Schellenberger, Palo Alto, CA (US);

Milton To, San Lorenzo, CA (US);

Tracy Young, Belmont, CA (US);

André Frenzel, Braunschweig, DE;

Philipp Kuhn, Braunschweig, DE;

Assignee:

Amunix Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61P 35/00 (2018.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 16/2809 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2319/30 (2013.01); C07K 2319/50 (2013.01);
Abstract

The disclosure describes antibody binding domains for cluster of differentiation 3 T cell receptor (CD3), antibody binding domains for epidermal growth factor receptor (EGFR), cleavable linker sequences, and protease-activatable bispecific fusion proteins such as protease-activatable T cell engagers, as well as uses and methods of treatment.


Find Patent Forward Citations

Loading…